Erenumab Suppliers & Bulk Manufacturers
Available Forms: Prefilled autoinjector
Available Strengths: 70 mg, 140 mg
Reference Brands: Aimovig (USA/EU)
Category:
Neurology
Erenumab is a monoclonal antibody used for the prevention of migraines in adults. It works by blocking the CGRP (Calcitonin Gene-Related Peptide) receptor, which plays a key role in migraine attacks. Administered as a subcutaneous injection once monthly, it is available in 70 mg and 140 mg strengths via prefilled pen or syringe. Erenumab helps reduce the frequency of migraine days and is generally well-tolerated.
Erenumab is available in Prefilled autoinjector
and strengths such as 70 mg, 140 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Erenumab is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Erenumab can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing